FDA Brief

Warning letters Drugs

FDA warning letter to

Lus Essentials LLC

High riskIssued May 14Posted May 19Center for Drug Evaluation and Research (CDER)

FDA warned Lus Essentials that its Dr. Yanhee skin treatment and lightening products are unapproved, misbranded drugs and contain high mercury.

What happened

FDA reviewed Lus Essentials' website in April 2026 and obtained a sample of two Dr. Yanhee product sets sold as skin treatment and skin lightening products. Laboratory analysis confirmed the products contain high levels of mercury. FDA says the product labeling does not declare that the products contain mercury.

What FDA found

  1. The products are unapproved new drugs because FDA says they are not generally recognized as safe and effective and have no approved drug application.

    FD&C Act sections 505(a) and 201(p), 21 U.S.C. 355(a) and 321(p)
  2. The products are misbranded because their labeling is false or misleading: it does not disclose that they contain mercury.

    FD&C Act sections 502(a) and 201(n), 21 U.S.C. 352(a) and 321(n)
  3. Selling or shipping these products in interstate commerce is prohibited.

    FD&C Act sections 301(a), 301(d), and 505(a), 21 U.S.C. 331(a), 331(d), and 355(a)

What FDA wants

FDA tells Lus Essentials to promptly address the violations and send a written response within 15 business days to FDAAdvisory@fda.hhs.gov. The response should include corrective steps, steps to prevent recurrence, related documentation, and reference number 728783.

Who should pay attention

  • retailers and online marketplaces selling imported skin-lightening creams
  • consumers using Dr. Yanhee acne or melasma sets
  • importers and brands sourcing skin treatment products from this seller

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. La Crema De Rebeca

    La Crema De Rebeca's skin-lightening cream is an unapproved, misbranded drug containing high mercury, FDA warns.

    High risk